We consider data clustering problems where partial grouping is known a priori. We formulate such biased grouping problems as a constrained optimization problem, where structural properties of the data define the goodness of a grouping and partial grouping cues define the feasibility of a grouping. We enforce grouping smoothness and fairness on labeled data points so that sparse partial grouping information can be effectively propagated to the unlabeled data. Considering the normalized cuts criterion in particular, our formulation leads to a constrained eigenvalue problem. By generalizing the Rayleigh-Ritz theorem to projected matrices, we find the global optimum in the relaxed continuous domain by eigendecomposition, from which a near-global optimum to the discrete labeling problem can be obtained effectively. We apply our method to real image segmentation problems, where partial grouping priors can often be derived based on a crude spatial attentional map that binds places with common salient features or focuses on expected object locations. We demonstrate not only that it is possible to integrate both image structures and priors in a single grouping process, but also that objects can be segregated from the background without specific object knowledge.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/tpami.2004.1262179 | DOI Listing |
Paediatr Drugs
January 2025
National Centre for Register-based Research, Aarhus University, Fuglesangs Allé 26, 8210, Aarhus V, Denmark.
Background And Objectives: Females of reproductive age are increasingly using attention deficit hyperactivity disorder (ADHD) medication, but its use during pregnancy and breastfeeding is largely unknown. The aim of this study is to examine the prevalence of ADHD medication fills during pregnancy and breastfeeding, including characteristics of these females and cohort differences over time.
Methods: We conducted a descriptive study using Danish nationwide registers.
AIDS Behav
January 2025
Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.
Military members and female sex workers (FSWs) may be more likely to acquire or transmit HIV. Mapping HIV transmission across these high-risk populations and identifying behaviors associated with sexual network clustering are needed for effective HIV prevention approaches. A cross-sectional study recruited participants newly diagnosed with HIV among militaries, civilians, and FSWs in Zambia, Senegal, and Democratic Republic of the Congo (DRC).
View Article and Find Full Text PDFStrahlenther Onkol
January 2025
Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Hebei Clinical Research Center for Radiation Oncology, 050011, Shijiazhuang, China.
Purpose: To evaluate the safety and efficacy of radiotherapy combined with chemoimmunotherapy (RCIT) versus chemoimmunotherapy (CIT) alone as first-line treatment for oligometastatic esophageal squamous cell carcinoma (OESCC) at initial diagnosis.
Methods: We retrospectively evaluated 140 patients newly diagnosed with OESCC who received RCIT or CIT as first-line treatment between June 2018 and December 2021. Among them, 76 patients were in the RCIT cohort and 64 patients in the CIT cohort.
Pharmacol Res
January 2025
School of Nursing, Hunan Normal University, Changsha, Hunan, 410013, China. Electronic address:
Background: Neoadjuvant chemoimmunotherapy emerged as a promising treatment for locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN). However, a comparison of clinical outcomes with neoadjuvant chemotherapy was lacking.
Objective: To provide evidence supporting clinical decision-making for neoadjuvant chemoimmunotherapy in LA-SCCHN treatment.
J Pharm Biomed Anal
January 2025
Clinical Institute of Laboratory Diagnostics, University Hospital Centre Osijek, J. Huttlera 4, Osijek 31 000, Croatia; Faculty of Medicine Osijek, JJ Strossmayer University of Osijek, J. Huttlera 4, Osijek 31 000, Croatia. Electronic address:
Ibrutinib and acalabrutinib, Bruton's tyrosine kinase inhibitors (BTKi) used for chronic lymphocytic leukemia (CLL) treatment, aim the same target but their off-target effects are different. The aim of this study was to use single-cell MALDI TOF mass spectrometry imaging to compare the CD19+ lymphocytes' mass spectra in untreated and ibrutinib- or acalabrutinib-treated subjects in order to better understand the therapeutic effect of BTKi. 180 cells from 9 male subjects divided in 3 groups (untreated, ibrutinib-treated and acalabrutinib-treated) were analyzed using MALDI-TOF mass spectrometry analyzer.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!